Research and Markets (http://www.researchandmarkets.com/research/d359mj/copd_partnering)
has announced the addition of the "COPD
Partnering 2009-2014" report to their offering.
The COPD Partnering 2009-2014 report provides understanding and access
to the COPD partnering deals and agreements entered into by the worlds
leading healthcare companies.
The COPD Partnering 2009-2014 provides understanding and access to the
COPD partnering deals and agreements entered into by the worlds leading
The report provides an analysis of COPD partnering deals. The majority
of deals are discovery or developmentstage whereby the licensee obtains
a right or an option right to license the licensors COPD technology.
These deals tend to be multicomponent, starting with collaborative R&D,
and commercialization of outcomes.
This data driven report contains over 70 links to online copies of
actual COPD deals and contract documents as submitted to the Securities
Exchange Commission by companies and their partners, where available.
Contract documents provide the answers to numerous questions about a
prospective partner's flexibility on a wide range of important issues,
many of which will have a significant impact on each party's ability to
derive value from the deal.
This data driven report includes:
- Trends in COPD dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- The leading COPD deals by value since 2009
In COPD Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Technology type
Each deal title links via Weblink to an online version of the deal
record and where available, the contract document, providing easy access
to each contract document on demand.
For more information visit http://www.researchandmarkets.com/research/d359mj/copd_partnering
[ Back To NFVZone's Homepage ]